SEC FORM 4
$161,850.87
CytomX Therapeutics, Inc. (CTMX)
Acquisition (code M) of 101,793 shares at $1.59 per share.
Reporting Person McCarthy Sean A. · Officer Title CEO · Transaction Code M
Traded Nov 6, 2025 · Disclosed Oct 16, 2026FILED +344 DAYS
Source: SEC Form 4 · 0001610717-26-000442 · filed 2026-10-16 · View filing →